ImmTAC
id:
immtac-177-910904
title:
ImmTAC
text:
ImmTACs are a class of bispecific biological drug being investigated for the treatment of cancer and viral infections which combines engineered cancer-recognizing TCRs with immune activating complexes. ImmTACs target cancerous or virally infected cells through binding human leukocyte antigen (HLA) presented peptide antigens and redirect the host's cytotoxic T cells to recognise and kill them. ImmTACs are fusion proteins that combine an engineered T Cell Receptor (TCR) based targeting system with
brand slug:
wiki
category slug:
encyclopedia
description:
Biological drug for the treatment of cancer
original url:
https://en.wikipedia.org/wiki/ImmTAC
date created:
2013-08-05T19:41:08Z
date modified:
2024-09-03T22:41:28Z
main entity:
{"identifier":"Q28455150","url":"https://www.wikidata.org/entity/Q28455150"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/91/ImmTAC_schematic_diagram.png","width":249,"height":275}
fields total:
13
integrity:
16